AssetMark Inc’s Arcadia Biosciences RKDA Stock Holding History

AssetMark Inc’s Portfolio RKDA Stock Details RKDA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-5	Closed	-$7	–	3645
2026 Q1	$7	Hold	5	–	–	﹤0.01%	3433
2025 Q4	$10	Hold	5	–	–	﹤0.01%	3361
2025 Q3	$17	Hold	5	–	–	﹤0.01%	3170
2025 Q2	$22	Hold	5	–	–	﹤0.01%	2984
2025 Q1	$15	Hold	5	–	–	﹤0.01%	2606
2024 Q4	$30	Hold	5	–	–	﹤0.01%	2569
2024 Q3	$14	Buy	+5	New	+$14	﹤0.01%	2241

Other funds holding RKDA

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

StoneX Group New York $2.48B AUM 33.54% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BWM

Bullock Wealth Management Bloomington, Indiana $231M AUM

AssetMark Inc's RKDA Position: Q2 2026 in Review

AssetMark Inc sold out of Arcadia Biosciences (RKDA) in Q2 2026, closing a stake of 5 shares — an estimated $7 sold.

AssetMark Inc first reported a position in RKDA in Q3 2024 and held it in 7 quarters. The position peaked at $30 in Q4 2024. 18 funds tracked by Wall St. Rank hold RKDA as of Q2 2026.

AssetMark Inc reported no remaining Arcadia Biosciences position as of Q2 2026 after selling out during the quarter.
AssetMark Inc sold 5 Arcadia Biosciences shares in Q2 2026, an estimated $7.
AssetMark Inc first reported a position in Arcadia Biosciences in Q3 2024 and held it in 7 quarters.
AssetMark Inc's Arcadia Biosciences position peaked at $30 in Q4 2024.
18 funds tracked by Wall St. Rank held Arcadia Biosciences as of Q2 2026.

Based on AssetMark Inc's 13F filing for Q2 2026, filed 30 Jul 2026.